Logo image of NA

NANO LABS LTD-CL A (NA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NA - KYG6391Y1281 - Common Stock

3.01 USD
0 (0%)
Last: 12/16/2025, 4:30:02 PM
3.01 USD
0 (0%)
After Hours: 12/16/2025, 4:30:02 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NA. NA was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of NA have multiple concerns. NA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year NA has reported negative net income.
NA had negative earnings in 4 of the past 5 years.
NA had negative operating cash flow in 4 of the past 5 years.
NA Yearly Net Income VS EBIT VS OCF VS FCFNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.65%, NA is doing worse than 73.21% of the companies in the same industry.
NA has a Return On Equity of -18.17%. This is in the lower half of the industry: NA underperforms 74.11% of its industry peers.
Industry RankSector Rank
ROA -7.65%
ROE -18.17%
ROIC N/A
ROA(3y)-27.35%
ROA(5y)-32.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NA Yearly ROA, ROE, ROICNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 29.27%, NA is doing worse than 70.54% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for NA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NA Yearly Profit, Operating, Gross MarginsNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

2

2. Health

2.1 Basic Checks

NA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NA has been reduced compared to 1 year ago.
NA has a better debt/assets ratio than last year.
NA Yearly Shares OutstandingNA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
NA Yearly Total Debt VS Total AssetsNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.69, we must say that NA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.69, NA is not doing good in the industry: 73.21% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.09 is on the high side and indicates that NA has dependencies on debt financing.
NA's Debt to Equity ratio of 1.09 is on the low side compared to the rest of the industry. NA is outperformed by 88.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACCN/A
WACC9.27%
NA Yearly LT Debt VS Equity VS FCFNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

2.3 Liquidity

A Current Ratio of 1.81 indicates that NA should not have too much problems paying its short term obligations.
NA has a worse Current ratio (1.81) than 76.79% of its industry peers.
A Quick Ratio of 1.76 indicates that NA should not have too much problems paying its short term obligations.
NA has a worse Quick ratio (1.76) than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.76
NA Yearly Current Assets VS Current LiabilitesNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M

1

3. Growth

3.1 Past

NA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -227.04%.
NA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -47.66%.
Measured over the past years, NA shows a small growth in Revenue. The Revenue has been growing by 1.30% on average per year.
EPS 1Y (TTM)-227.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.89%
Revenue 1Y (TTM)-47.66%
Revenue growth 3Y1.3%
Revenue growth 5YN/A
Sales Q2Q%-66.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NA Yearly Revenue VS EstimatesNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 200M 400M 600M 800M

0

4. Valuation

4.1 Price/Earnings Ratio

NA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NA Price Earnings VS Forward Price EarningsNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NA Per share dataNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for NA!.
Industry RankSector Rank
Dividend Yield 0%

NANO LABS LTD-CL A

NASDAQ:NA (12/16/2025, 4:30:02 PM)

After market: 3.01 0 (0%)

3.01

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-15 2025-08-15
Earnings (Next)03-23 2026-03-23
Inst Owners7.43%
Inst Owner Change-62.72%
Ins Owners1.39%
Ins Owner Change0%
Market Cap196.63M
Revenue(TTM)41.00M
Net Income(TTM)-113.00M
AnalystsN/A
Price TargetN/A
Short Float %1.69%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 33.8
P/FCF N/A
P/OCF N/A
P/B 2.23
P/tB 2.41
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.09
BVpS1.35
TBVpS1.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.65%
ROE -18.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.27%
FCFM N/A
ROA(3y)-27.35%
ROA(5y)-32.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 1.76
Altman-Z 0.69
F-ScoreN/A
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)1486.25%
Cap/Depr(5y)1011.3%
Cap/Sales(3y)76.42%
Cap/Sales(5y)59.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-227.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-47.66%
Revenue growth 3Y1.3%
Revenue growth 5YN/A
Sales Q2Q%-66.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y62.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.14%
OCF growth 3YN/A
OCF growth 5YN/A

NANO LABS LTD-CL A / NA FAQ

Can you provide the ChartMill fundamental rating for NANO LABS LTD-CL A?

ChartMill assigns a fundamental rating of 1 / 10 to NA.


What is the valuation status for NA stock?

ChartMill assigns a valuation rating of 0 / 10 to NANO LABS LTD-CL A (NA). This can be considered as Overvalued.


What is the profitability of NA stock?

NANO LABS LTD-CL A (NA) has a profitability rating of 0 / 10.